Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMG1 pseudogene 3 (SMG1P3) is a processed pseudogene related to the SMG1 gene, which encodes a serine/threonine-protein kinase involved in nonsense-mediated mRNA decay (NMD)[3][7]. SMG1P3 itself is not transcribed into a functional protein product and thus is not considered functionally active in biological processes. It is sometimes referenced in genomic annotation due to sequence similarity to the functional SMG1 gene, but it does not play a role in therapeutic targeting, disease biology, or molecular function in cells[3][7][8]. SMG1P3 should not be confused with SMG1, which is a functional kinase involved in the NMD pathway and DNA damage response, and is investigated as a potential therapeutic target in some contexts. The designation "pseudogene" in SMG1P3 means it lacks protein-coding capacity and functional activity[7][3][8].
Not applicable; no mechanism due to pseudogene status
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SMG1 pseudogene 3 (SMG1P3).